Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

1

Revenue 2017

Pfizer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Pfizer's sales performance.

Pfizer

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more

In the course of its evidence gathering, the committee spoke to numerous UK pharma leaders, including Pfizer UK’s Eric Nordkamp, MSD’s Louise Houson and J&J’s Mark Hicken -

Pfizer takes aim at UK’s health tech industry

Pfizer takes aim at UK’s health tech industry Pfizer takes aim at UK’ s health tech industry. Offers start-ups a share of a £56k grant. ... The successful start-ups will benefit from access to Pfizer’s network of global partners, including the NHS.

FDA panel undermines Lilly and Incyte’s baricitinib hopes

FDA panel undermines Lilly and Incyte’s baricitinib hopes But analysts think the drug faces an uphill battle now to win market share from Pfizer’s Xeljanz (tofacitinib), the first JAK inhibitor to reach the market for RA in the

P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit Pfizer has also been trying to agree a sale for its consumer health unit, but has had no luck so far, with GSK and Reckitt Benckiser both opting not to proceed

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics